Clinical Trials Overview
A clinical trial is a type of research study involving patients or healthy volunteers that is designed to evaluate whether a potential new treatment is safe and effective. In some clinical trials, participants may be randomly assigned to receive either the potential new treatment or a placebo (a compound that looks like the study drug but does not contain active ingredients). Your participation in a clinical trial contributes significantly to medical research and to the potential development of new treatment options for a disease or condition.
miRagen is actively enrolling the following clinical trials for patients with certain blood cancers or a history of keloids:
- SOLAR, a Phase 2 clinical trial of cobomarsen (MRG-106) in patients with cutaneous T-cell lymphoma (CTCL), mycosis fungoides (MF) subtype
- Phase 1 clinical trial of cobomarsen (MRG-106) in patients with adult T-cell leukemia/lymphoma (ATLL), chronic lymphocytic leukemia (CLL) and diffuse large B-cell lymphoma (DLBCL)
- Phase 2 clinical trial of remlarsen (MRG-201) in participants with a history of keloids
For more information about miRagen clinical trials, please contact the miRagen Medical and Patient Liaison at (720) 643-5200.
If you are a patient enrolled in a miRagen clinical trial and you have questions regarding data privacy, please contact the miRagen Data Protection Officer (DPO) at (720) 643-5200.